Alzheimer's disease (AD) is the most common neurodegenerative disorder caused by neuronal loss that results in cognitive and functional impairment. Formation of neurofibrillary tangles composed of abnormal hyperphosphorylation of tau protein is one of the major pathological hallmarks of AD. Importantly, several neurodegenerative disorders, including AD, are associated with abnormal protein phosphorylation events. However, little is known thus far on global protein phosphorylation changes in AD. We report a phosphoproteomics study examining the frontal gyrus of people with AD and age-matched cognitively normal subjects, using tandem mass tag (TMT) multiplexing technology along with immobilized metal affinity chromatography to enrich phosphopeptides. We identified 4631 phosphopeptides corresponding to 1821 proteins with liquid chromatography-mass spectrometry (MS)/MS analysis on an Orbitrap Fusion Lumos Tribrid mass spectrometer. Of these, 504 phosphopeptides corresponding to 350 proteins were significantly altered in the AD brain: 389 phosphopeptides increased whereas 115 phosphopeptides decreased phosphorylation. We observed significant changes in phosphorylation of known as well as novel molecules. Using targeted parallel reaction monitoring experiments, we validated the phosphorylation of microtubule-associated protein tau and myristoylated alanine-rich protein kinase C substrate (MARCKS) in control and AD (Control = 6, AD = 11) brain samples. In conclusion, our study provides new evidence on alteration of RNA processing and splicing, neurogenesis and neuronal development, and metabotropic glutamate receptor 5 (GRM5) calcium signaling pathways in the AD brain, and it thus offers new insights to accelerate diagnostics and therapeutics innovation in AD.
Get full access to this article
View all access options for this article.
References
1.
AbdelmohsenK, and GorospeM. (2012). RNA-binding protein nucleolin in disease. RNA Biol, 9, 799–808.
2.
AlonsoA, ZaidiT, NovakM, Grundke-IqbalI, and IqbalK. (2001). Hyperphosphorylation induces self-assembly of tau into tangles of paired helical filaments/straight filaments. Proc Natl Acad Sci U S A, 98, 6923–6928.
3.
AlonsoAD, Di ClericoJ, LiB, et al. (2010). Phosphorylation of tau at Thr212, Thr231, and Ser262 combined causes neurodegeneration. J Biol Chem, 285, 30851–30860.
4.
ArditoF, GiulianiM, PerroneD, TroianoG, and Lo MuzioL. (2017). The crucial role of protein phosphorylation in cell signaling and its use as targeted therapy (Review). Int J Mol Med, 40, 271–280.
5.
BaiB, HalesCM, ChenPC, et al. (2013). U1 small nuclear ribonucleoprotein complex and RNA splicing alterations in Alzheimer's disease. Proc Natl Acad Sci U S A, 110, 16562–16567.
6.
BegcevicI, BrincD, BrownM, et al. (2018). Brain-related proteins as potential CSF biomarkers of Alzheimer's disease: A targeted mass spectrometry approach. J Proteomics, 182, 12–20.
7.
BerridgeMJ. (2013). Dysregulation of neural calcium signaling in Alzheimer disease, bipolar disorder and schizophrenia. Prion, 7, 2–13.
8.
BlackwellKT, and Jedrzejewska-SzmekJ. (2013). Molecular mechanisms underlying neuronal synaptic plasticity: Systems biology meets computational neuroscience in the wilds of synaptic plasticity. Wiley Interdiscip Rev Syst Biol Med, 5, 717–731.
9.
BononiA, AgnolettoC, De MarchiE, et al. (2011). Protein kinases and phosphatases in the control of cell fate. Enzyme Res, 2011, 329098.
10.
CarlomagnoY, ChungDC, YueM, et al. (2017). An acetylation-phosphorylation switch that regulates tau aggregation propensity and function. J Biol Chem, 292, 15277–15286.
11.
ChevallierNL, SorianoS, KangDE, et al. (2005). Perturbed neurogenesis in the adult hippocampus associated with presenilin-1 A246E mutation. Am J Pathol, 167, 151–159.
12.
ColeAR, NobleW, van AaltenL, et al. (2007). Collapsin response mediator protein-2 hyperphosphorylation is an early event in Alzheimer's disease progression. J Neurochem, 103, 1132–1144.
13.
DammerEB, LeeAK, DuongDM, et al. (2015). Quantitative phosphoproteomics of Alzheimer's disease reveals cross-talk between kinases and small heat shock proteins. Proteomics, 15, 508–519.
14.
DeribeYL, PawsonT, and DikicI. (2010). Post-translational modifications in signal integration. Nat Struct Mol Biol, 17, 666–672.
15.
DukaV, LeeJH, CredleJ, et al. (2013). Identification of the sites of tau hyperphosphorylation and activation of tau kinases in synucleinopathies and Alzheimer's diseases. PLoS One, 8, e75025.
16.
Fernandez-ChaconR, KonigstorferA, GerberSH, et al. (2001). Synaptotagmin I functions as a calcium regulator of release probability. Nature, 410, 41–49.
17.
FialovaL, BartosA, and SvarcovaJ. (2017). Neurofilaments and tau proteins in cerebrospinal fluid and serum in dementias and neuroinflammation. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub, 161, 286–295.
18.
GendronTF, C9ORF72 Neurofilament StudyGroup, DaughrityLM, et al. (2017). Phosphorylated neurofilament heavy chain: A biomarker of survival for C9ORF72-associated amyotrophic lateral sclerosis. Ann Neurol, 82, 139–146.
19.
GhoshalN, Garcia-SierraF, WuuJ, et al. (2002). Tau conformational changes correspond to impairments of episodic memory in mild cognitive impairment and Alzheimer's disease. Exp Neurol, 177, 475–493.
20.
HampelH, BlennowK, ShawLM, et al. (2010). Total and phosphorylated tau protein as biological markers of Alzheimer's disease. Exp Gerontol, 45, 30–40.
21.
HartwigJH, ThelenM, RosenA, et al. (1992). MARCKS is an actin filament crosslinking protein regulated by protein kinase C and calcium-calmodulin. Nature, 356, 618–622.
22.
HayanoT, YanagidaM, YamauchiY, et al. (2003). Proteomic analysis of human Nop56p-associated pre-ribosomal ribonucleoprotein complexes. Possible link between Nop56p and the nucleolar protein treacle responsible for Treacher Collins syndrome. J Biol Chem, 278, 34309–34319.
23.
IijimaK, GattA, and Iijima-AndoK. (2010). Tau Ser262 phosphorylation is critical for Abeta42-induced tau toxicity in a transgenic Drosophila model of Alzheimer's disease. Hum Mol Genet, 19, 2947–2957.
24.
JinK, GalvanV, XieL, et al. (2004). Enhanced neurogenesis in Alzheimer's disease transgenic (PDGF-APPSw,Ind) mice. Proc Natl Acad Sci U S A, 101, 13363–13367.
25.
KimuraT, YamamotoH, TakamatsuJ, et al. (2000). Phosphorylation of MARCKS in Alzheimer disease brains. Neuroreport, 11, 869–873.
26.
Ksiezak-RedingH, LiuWK, and YenSH. (1992). Phosphate analysis and dephosphorylation of modified tau associated with paired helical filaments. Brain Res, 597, 209–219.
27.
KulakNA, PichlerG, ParonI, NagarajN, and MannM. (2014). Minimal, encapsulated proteomic-sample processing applied to copy-number estimation in eukaryotic cells. Nat Methods, 11, 319–324.
28.
Leshchyns'kaI, LiewHT, ShepherdC, et al. (2015). Abeta-dependent reduction of NCAM2-mediated synaptic adhesion contributes to synapse loss in Alzheimer's disease. Nat Commun, 6, 8836.
29.
LiuY, LeeJW, and AckermanSL. (2015). Mutations in the microtubule-associated protein 1A (Map1a) gene cause Purkinje cell degeneration. J Neurosci, 35, 4587–4598.
30.
MaRH, ZhangY, HongXY, et al. (2017). Role of microtubule-associated protein tau phosphorylation in Alzheimer's disease. J Huazhong Univ Sci Technolog Med Sci, 37, 307–312.
31.
MakiharaH, NakaiS, OhkuboW, et al. (2016). CRMP1 and CRMP2 have synergistic but distinct roles in dendritic development. Genes Cells, 21, 994–1005.
32.
ManningG, WhyteDB, MartinezR, HunterT, and SudarsanamS. (2002). The protein kinase complement of the human genome. Science, 298, 1912–1934.
33.
MorgadoAL, XavierJM, DionisioPA, et al. (2015). MicroRNA-34a modulates neural stem cell differentiation by regulating expression of synaptic and autophagic proteins. Mol Neurobiol, 51, 1168–1183.
34.
PalmqvistS, SchollM, StrandbergO, et al. (2017). Earliest accumulation of beta-amyloid occurs within the default-mode network and concurrently affects brain connectivity. Nat Commun, 8, 1214.
35.
PingL, DuongDM, YinL, et al. (2018). Global quantitative analysis of the human brain proteome in Alzheimer's and Parkinson's Disease. Sci Data, 5, 180036.
36.
PorteliusE, BrinkmalmG, PanneeJ, et al. (2017). Proteomic studies of cerebrospinal fluid biomarkers of Alzheimer's disease: An update. Expert Rev Proteomics, 14, 1007–1020.
37.
PrasadTS, KandasamyK, and PandeyA. (2009). Human Protein Reference Database and Human Proteinpedia as discovery tools for systems biology. Methods Mol Biol, 577, 67–79.
38.
RakaF, Di SebastianoAR, KulhawySC, et al. (2015). Ca(2+)/calmodulin-dependent protein kinase II interacts with group I metabotropic glutamate and facilitates receptor endocytosis and ERK1/2 signaling: Role of beta-amyloid. Mol Brain, 8, 21.
39.
RennerM, LacorPN, VelascoPT, et al. (2010). Deleterious effects of amyloid beta oligomers acting as an extracellular scaffold for mGluR5. Neuron, 66, 739–754.
40.
RodriguezJJ, and VerkhratskyA. (2011). Neurogenesis in Alzheimer's disease. J Anat, 219, 78–89.
41.
SandersLC, MatsumuraF, BokochGM, and de LanerolleP. (1999). Inhibition of myosin light chain kinase by p21-activated kinase. Science, 283, 2083–2085.
42.
SatheG, NaCH, RenuseS, et al. (2018). Phosphotyrosine profiling of human cerebrospinal fluid. Clin Proteomics, 15, 29.
43.
SatheG, NaCH, RenuseS, et al. (2019). Quantitative proteomic profiling of cerebrospinal fluid to identify candidate biomarkers for Alzheimer's disease. Proteomics Clin Appl, 13, e1800105.
44.
SatheG, PintoSM, SyedN, et al. (2016). Phosphotyrosine profiling of curcumin-induced signaling. Clin Proteomics, 13, 13.
45.
ShinRW, IwakiT, KitamotoT, and TateishiJ. (1991). Hydrated autoclave pretreatment enhances tau immunoreactivity in formalin-fixed normal and Alzheimer's disease brain tissues. Lab Invest, 64, 693–702.
46.
SternbergerNH, SternbergerLA, and UlrichJ. (1985). Aberrant neurofilament phosphorylation in Alzheimer disease. Proc Natl Acad Sci U S A, 82, 4274–4276.
47.
SzklarczykD, FranceschiniA, WyderS, et al. (2015). STRING v10: Protein-protein interaction networks, integrated over the tree of life. Nucleic Acids Res, 43, D447–D452.
48.
TaupinP. (2006). Neurogenesis in the adult central nervous system. C R Biol, 329, 465–475.
49.
ThinakaranG, and SisodiaSS. (2006). Presenilins and Alzheimer disease: The calcium conspiracy. Nat Neurosci, 9, 1354–1355.
50.
TomasevicN, and PeculisBA. (2002). Xenopus LSm proteins bind U8 snoRNA via an internal evolutionarily conserved octamer sequence. Mol Cell Biol, 22, 4101–4112.
51.
TriplettJC, SwomleyAM, CaiJ, KleinJB, and ButterfieldDA. (2016). Quantitative phosphoproteomic analyses of the inferior parietal lobule from three different pathological stages of Alzheimer's disease. J Alzheimers Dis, 49, 45–62.
52.
TyanovaS, TemuT, SinitcynP, et al. (2016). The Perseus computational platform for comprehensive analysis of (prote)omics data. Nat Methods, 13, 731–740.
53.
UlloaL, Montejo de GarciniE, Gomez-RamosP, MoranMA, and AvilaJ. (1994). Microtubule-associated protein MAP1B showing a fetal phosphorylation pattern is present in sites of neurofibrillary degeneration in brains of Alzheimer's disease patients. Brain Res Mol Brain Res, 26, 113–122.
54.
VindryC, MarnefA, BroomheadH, et al. (2017). Dual RNA processing roles of Pat1b via cytoplasmic Lsm1–Lsm7 and Nuclear Lsm2–Lsm8 complexes. Cell Rep, 20, 1187–1200.
55.
WintherM, BerezinV, and WalmodPS. (2012). NCAM2/OCAM/RNCAM: Cell adhesion molecule with a role in neuronal compartmentalization. Int J Biochem Cell Biol, 44, 441–446.
56.
WirthsO, BreyhanH, MarcelloA, et al. (2010). Inflammatory changes are tightly associated with neurodegeneration in the brain and spinal cord of the APP/PS1KI mouse model of Alzheimer's disease. Neurobiol Aging, 31, 747–757.
57.
WongJ. (2013). Altered expression of RNA splicing proteins in Alzheimer's disease patients: Evidence from two microarray studies. Dement Geriatr Cogn Dis Extra, 3, 74–85.
58.
WungJK, PerryG, KowalskiA, et al. (2007). Increased expression of the remodeling- and tumorigenic-associated factor osteopontin in pyramidal neurons of the Alzheimer's disease brain. Curr Alzheimer Res, 4, 67–72.
59.
ZahidS, OellerichM, AsifAR, and AhmedN. (2012). Phosphoproteome profiling of substantia nigra and cortex regions of Alzheimer's disease patients. J Neurochem, 121, 954–963.
60.
ZhangZH, MaFF, ZhangH, and XuXH. (2017). MARCKS is necessary for oligodendrocyte precursor cell maturation. Neurochem Res, 42, 2933–2939.
61.
ZhongJ, KimMS, ChaerkadyR, et al. (2012). TSLP signaling network revealed by SILAC-based phosphoproteomics. Mol Cell Proteomics, 11, M112.017764.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
